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Infections are associated with extensive platelet
consumption, representing a high risk for health.
However, the mechanism coordinating the rapid
regeneration of the platelet pool during such
stress conditions remains unclear. Here, we report
that the phenotypic hematopoietic stem cell (HSC)
compartment contains stem-like megakaryocyte-
committed progenitors (SL-MkPs), a cell population
that shares many features with multipotent HSCs
and serves as a lineage-restricted emergency
pool for inflammatory insults. During homeostasis,
SL-MkPs are maintained in a primed but quies-
cent state, thus contributing little to steady-state
megakaryopoiesis. Even though lineage-specific
megakaryocyte transcripts are expressed, protein
synthesis is suppressed. In response to acute
inflammation, SL-MkPs become activated, resulting
in megakaryocyte protein production from pre-
existing transcripts and a maturation of SL-MkPs
and other megakaryocyte progenitors. This results
in an efficient replenishment of platelets that are
lost during inflammatory insult. Thus, our study re-
veals an emergency machinery that counteracts
life-threatening platelet depletions during acute
inflammation.422 Cell Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc.INTRODUCTION
The continuous production of blood and immune cells is regu-
lated by a small number of multipotent and self-renewing
hematopoietic stem cells (HSCs) residing in the bone marrow
of adult mammals (Orkin and Zon, 2008). In response to bone
marrow injury or infection, long-term quiescent HSCs are effi-
ciently recruited into the cell cycle and return back to quiescence
after re-establishment of homeostasis (Baldridge et al., 2010;
Essers et al., 2009; Wilson et al., 2008). Positioned at the
apex of the hierarchically organized hematopoietic system,
HSCs generate a series of progenitor cells that undergo
several consecutive commitment steps, becoming progressively
restricted in their lineage potential and finally producing unipo-
tent progenitors (Orkin and Zon, 2008). Megakaryocytes (Mks)
are large, polyploid cells that release platelets into the circulation
(Machlus and Italiano, 2013). According to the classical model
of hematopoiesis, each mature Mk derives from an HSC that
sequentially transitioned through the multipotent progenitor
(MPP), common myeloid progenitor (CMP), Mk-erythroid pro-
genitor (MEP), and Mk progenitor (MkP) states, followed by
endomitosis to generate a mature Mk (Machlus and Italiano,
2013). However, the first evidence for a potential bypass of
some intermediate states from HSCs toward Mks was pro-
vided when transcriptional profiling revealed expression of
Mk transcripts in highly purified HSCs (Ma˚nsson et al., 2007).
More recently, mRNA expression of the Mk marker von Wille-
brand factor (Vwf) and the surface receptor c-Kit were sug-
gested to be indicative of a platelet-biased, but multipotent
HSC sub-population (Sanjuan-Pla et al., 2013; Shin et al., 2014).
Moreover, the existence of Mk-lineage restricted cells with
high self-renewal activity in the phenotypic HSC compartment
was proposed based on single-cell transplantation experiments
(Yamamoto et al., 2013). However, a molecular and cellular
characterization of these potent Mk-restricted cells is lacking
and the purpose of Mk-lineage priming effects and potential
physiological benefits of shortcuts into the Mk lineage remain
unclear.
Recent reports highlight the importance of platelets as in-
flammatory and immune cells in addition to their well-known
function in thrombosis (Semple et al., 2011; Yeaman, 2014).
Systemic inflammation associated with acute infections triggers
the release of immunomodulatory agents and the interaction of
platelets with neutrophils to facilitate the formation of neutrophil
extracellular traps (NETs) (Jenne et al., 2013; Yeaman, 2014).
This provokes a rapid consumption of platelets, resulting in a
transient thrombocytopenia (Stohlawetz et al., 1999; Tacchini-
Cottier et al., 1998). During acute inflammation, low platelet
levels are associated with a loss of vascular integrity and hemor-
rhage, as well as septic shock, resulting in increased mortality
(Goerge et al., 2008; Xiang et al., 2013). Therefore, a fast recov-
ery of platelet levels is essential. However, the exact mechanism
by which platelet levels are rapidly regenerated after acute
inflammation remains unknown.
Here, we report the existence of potent stem-like Mk-
committed progenitors (SL-MkPs) within the phenotypic HSC
compartment. Under stress conditions like viral infections, acute
inflammatory signaling triggers cell cycle activation of quiescent
SL-MkPs and Mk protein production, which drives a rapid matu-
ration program of SL-MkPs and other MkPs. Together, this me-
diates an efficient platelet recovery after inflammation-induced
thrombocytopenia.
RESULTS
Inflammatory Signaling Drives Megakaryocytic Protein
Expression in Phenotypic HSCs
Inflammatory signaling during infection triggers a rapid depletion
of circulating platelets and other blood cells. To study the he-
matopoietic system during such stress conditions, we mimicked
a viral infection by inducing acute inflammation through admin-
istration of a single dose of polyinosinic:polycytidylic acid (pI:C)
to mice. As expected, inflammation was associated with dra-
matic reduction in platelet numbers, but homeostatic blood
platelet levels were restored within a few days, suggesting inten-
sive platelet regeneration (Figure 1A). To elucidate which cell
types might be involved in this rapid platelet regeneration pro-
gram, we measured the expression of CD41 (Itga2b), an early
marker of megakaryocytic maturation, in distinct cell popula-
tions of the hematopoietic stem and progenitor cell compart-
ment during homeostasis and 16 hr after pI:C induction (see
Supplemental Information; Figures S1A–S1C for gating strate-
gies under inflammation). In accordance with previous reports,
CD41 was expressed in MkPs and at low levels in a subset of
HSCs during homeostasis (Gekas and Graf, 2013). Unexpect-
edly, all investigated cell types potentially capable of generating
Mks robustly increased CD41 protein expression upon pI:C
treatment, including MkPs, MEPs, and, most surprisingly,Cephenotypic HSCs, whereas other cell types remained unaf-
fected (Figure 1B). Since inflammation induced the strongest
relative upregulation of CD41 in the HSC compartment, we sub-
jected fluorescence activated cell sorting (FACS) purified HSCs
(LincKit+CD150+CD48) and progenitors (LincKit+CD150+
CD48+) from control and pI:C treated mice to mass spectrom-
etry-based quantitative proteomics in order to globally charac-
terize inflammation-mediated changes in the HSC proteome.
Of a total of 7,492 identified proteins, 162 proteins were signifi-
cantly changed in HSCs upon induction of inflammation (Table
S1). As expected, pI:C treatment triggered the production of
typical interferon (IFN) response proteins (Figures 1C, 1D,
S1D, and S1E), but also revealed a significant increase of 28
proteins typically expressed in mature Mks and platelets (Fig-
ures 1C, 1D, and S1E). These included CD41 (Itga2b) and its
partner CD61 (Itgb3), components of the GPIb-IX-V complex,
platelet-selectin (Selp), the platelet and Mk-specific b1 tubulin
(Tubb1), as well as many proteins characteristic for Mk and
platelet alpha-granules, such as Vwf and platelet factor 4 (Pf4).
In concert with our finding that inflammation-driven Mk protein
increase is highest in HSCs (Figure 1B), the upregulation of Mk
proteins in LincKit+CD150+CD48+ progenitors was almost
absent (Figures 1C, 1D, S1E, and S1F).
Since pI:C administration triggers a wide production and
secretion of type-I IFNs in vivo, we hypothesized that type-I
IFN signaling might be involved in regulating the production of
Mk proteins in HSCs. Accordingly, administration of recombi-
nant IFNa phenocopied pI:C injections with regards to Mk pro-
tein upregulation (Figure S1G), and the pI:C-mediated increase
in Mk proteins was completely absent in HSCs from IFNa re-
ceptor (IFNAR) knockout mice (Figures 1D and S1E). The anal-
ysis of forward, reverse, and 50:50 wild-type (WT):IFNAR/
bone marrow chimeras revealed that type-I IFN signaling
directly instructs Mk protein expression in phenotypic HSCs
(Figure S1H). Canonical type-I IFN signaling results in the acti-
vation of the signal transducer STAT1 and crosstalk signaling
to mTOR has been reported (Platanias, 2005). Therefore, we
investigated the involvement of STAT1 and mTOR in pI:C-
mediated Mk protein upregulation. Either the pharmacological
inhibition of mTOR using rapamycin or the genetic deletion of
STAT1 reduced inflammation-mediated Mk protein upregula-
tion, suggesting that both pathways participate in the regula-
tion of Mk protein production in HSCs (Figures S1I–S1K). In
contrast, stem cell antigen 1 (Sca-1), involved in pI:C-induced
cell cycle activation of HSCs, was not required for pI:C-induced
Mk protein expression (Figure S1L). Moreover, single adminis-
trations of lipopolysaccharide (LPS), mimicking a bacterial
infection, or recombinant tumor necrosis factor alpha (TNFa),
a cytokine involved in mediating acute inflammation, also trig-
gered an increase of Mk proteins in HSCs comparable to pI:C
(Figure 1E). In contrast to pI:C, LPS-mediated Mk protein
expression in HSCs was mediated by TLR4/MYD88/TRIF-
signaling (Figure S1M). Reducing platelet levels using a platelet
depletion antibody without triggering inflammation induced
only a minor increase of Mk proteins, further highlighting the
importance of inflammatory signaling (Figure S1N). Together,
these data demonstrate that inflammatory signaling associated
with infections directly triggers Mk protein expression in pheno-
typic HSCs.ll Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc. 423
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Figure 1. Inflammation Drives Megakaryocytic Protein Expression in HSCs
(A) Platelet counts upon treatment with pI:C.
(B) Flow cytometric analysis of CD41 expression in distinct stem and progenitor compartments of PBS and pI:C treated mice 16 hr after injection.
(C and D) Mass spectrometry-based quantitative proteome analysis of HSCs (LincKit+CD150+CD48) and progenitors (LincKit+CD150+CD48+) isolated from
WT and IFNAR/ mice 16 hr after PBS or pI:C treatment.
(C) Scatter plot of fold changes in protein levels upon pI:C treatment in HSCs and progenitors of WT mice.
(D) Heatmap illustrating protein log2 fold changes upon pI:C treatment in WT and IFNAR/ HSCs and progenitors for the overlapping proteins of the Venn
diagram.
(E) Flow cytometric analysis of CD41 and CD62P expression in HSCs 16 hr after pI:C, LPS and TNFa administration.
In (A), (B), and (E), data are presented as mean ± SEM with nR 3. The significance was determined using an unpaired, two-tailed student’s t test (*p% 0.05,
**p% 0.01, ***p% 0.001, ****p% 0.0001, and non-significant: NS). See also Figure S1.SL-MkPs within the Phenotypic HSC Compartment
Increase Mk Protein Expression upon Acute
Inflammation
Recent reports identified multipotent HSCs with intrisinc Mk bias
aswell as unipotentMk-committed progenitors in the phenotypic
HSCcompartment (Sanjuan-Pla et al., 2013; Shin et al., 2014; Ya-
mamoto et al., 2013). To determine whether inflammation-driven
Mk protein expression takes place primarily in multipotent HSCs
or in other cell types present in the phenotypic HSCs compart-
ment and to investigate whether elevated Mk protein levels are
associated with Mk lineage fate decisions, we made use of
high-throughput single-cell ex vivo lineage tracking (Figure 2A).
Single LT-HSCswere sorted into differentiationmedium contain-
ing fluorescently labeled antibodies, and the morphology and
expression of lineage makers of individual cells was tracked in
clonally expanded progeny by daily fluorescence microscopy.
This allowed a time-resolved analysis of ex vivo differentiation
in a quantitative manner. As expected, the majority of HSCs
fromhomeostaticmice formed large ‘‘mixed’’ colonies containing
both myeloid and megakaryocytic cells. However, a fraction of424 Cell Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc.the phenotypic HSCs generated exclusively mature Mks, sug-
gesting that these cells were committed to Mk-lineage (Figures
2B, S2A, and S2B). This sets them apart from multipotent, but
Mk-biased, populations such as Vwf+ HSCs (Sanjuan-Pla et al.,
2013), but is in accordance with a recent single-cell transplanta-
tion study identifying Mk-committed progenitors with high self-
renewal potential in the HSC compartment (Yamamoto et al.,
2013). While some phenotypic HSCs directly gave rise to single
Mks, others formed large colonies consisting of up to hundreds
ofmatureMks (FiguresS2AandS2B). Thesepotent stemcell-like
megakaryocyte-committed progenitors (SL-MkPs) are distinct to
classical MkPs and exist within the phenotypic HSC pool during
homeostasis (FiguresS2AandS2B). Thenumber of single-sorted
HSCs giving rise to ‘‘Mk only’’ colonies during homeostasis
and inflammation was the same (Figure 2B), suggesting that
commitment of multipotent HSCs to SL-MkPs occurs during
homeostasis, and inflammatory signaling induces Mk protein
expressionwithout affecting lineage fate decisions. To determine
which cell types increase Mk protein levels upon inflammation,
we retrospectively assigned CD41 fluorescence intensity values
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Figure 2. Stem-like Mk-Committed Progenitors within the Phenotypic HSC Compartment Increase Mk Protein Levels upon Acute
Inflammation
(A–C) Ex vivo lineage tracking of single LT-HSCs from PBS and pI:C treated mice. The representative data for one out of two independently performed
experiments is shown. (A) Illustration of experimental approach. (B) Distribution of colony types formed at day 14 of ex vivo liquid culture. (C) CD41 surface
expression of single-sorted LT-HSCs and MkPs giving rise to the indicated colony types.
(D and E) Transplantation of LT-HSC CD41 sub-populations. The ACTB-Tomato mice were treated with PBS or pI:C, after 16 hr, 40 LT-HSCs or 300 MkPs were
transplanted into lethally irradiated WT recipients. (D) Illustration of experimental approach. (E) Results. The pie charts represent relative lineage contributions.
For (C) and (E), the data are presented as mean ± SEM. The significance was determined using a Mann-Whitney-Wilcoxon test (*p % 0.05, **p % 0.01,
***p% 0.001, ****p% 0.0001, and non-significant: NS). See also Figure S2.from single-sorted HSCs to the colony types they formed (Fig-
ure2C). PhenotypicHSCsgeneratingmixedcolonies showedmi-
nor, but significant, increase in CD41 expression upon inflamma-
tion, whereas cells generating ‘‘myeloid only’’ colonies remained
unaffected from CD41 upregulation. In contrast, SL-MkPs (i.e.,
cells giving rise to Mk only colonies) robustly increased CD41
expression to elevated levels upon inflammation, suggesting
that SL-MkPs are the primary source of Mk protein expression
upon pI:C treatment within the phenotypic HSC compartment.
To confirm this finding in vivo, we sub-fractionated LT-HSCs
from ACTB-tdTomato mice based on their CD41 signal into
CD41low and med for PBS treated mice and CD41low, med,
and high for pI:C treated mice and traced the generation of
tomato-positive lineage cells in the blood (Figures 2D and 2E).
In line with our single-cell ex vivo data, CD41low and CD41med
HSCs from both PBS and pI:C treatedmice showedmultilineage
reconstitution (Gekas and Graf, 2013), whereas CD41high HSCs
from pI:C treated mice exclusively generated platelets in a tran-
sient manner, demonstrating that these cells were committed to
the Mk lineage (Figure 2E). In contrast, MkPs generated a much
lower platelet chimerism, confirming that CD41highHSCs repre-
sent potent SL-MkPs that are superior to classical MkPs in theirCeplatelet generation capacity. Together, these data demonstrate
that commitment of HSCs to SL-MkPs appears during homeo-
stasis. While SL-MkPs express similar levels of Mk proteins
compared to HSCs during homeostasis, inflammatory signaling
triggersMk protein expression in SL-MkPswithout affecting line-
age commitment of HSCs to SL-MkPs.
Inflammation Drives Functional and Cellular Maturation
of SL-MkPs and MkPs
To investigate whether increased Mk protein expression
might be attributed to an inflammation-driven maturation of
SL-MkPs, we performed kinetic analyses of Mk generation
ex vivo. While single-sorted control MkPs did not expand, form
small Mk colonies, andmature within the first 2–3 days in culture,
SL-MkPs (phenotypic HSCs generating Mk only colonies) from
homeostatic mice expanded in an immature state until day
7–8, matured late, and formed large Mk colonies (Figures 3A,
S2B, and S2C). In contrast, SL-MkPs from pI:C treated mice
generated mature Mks much faster (Figures 3A and S2C),
suggesting that inflammation triggered efficient maturation of
SL-MkPs. The induced maturation of SL-MkPs was associated
with a reduced expansion of immature cells and thus with all Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc. 425
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Figure 3. Inflammation Drives a Cellular Mk Maturation Program at Distinct Levels of Megakaryopoiesis
(A) Time until first mature Mk cell appears in the culture of Mk only colonies (left). The mean number of mature Mks at day 1–4 after culture of Mk only colonies
(right).
(B) Mk colony size (left) and Mk maturation time (right) of Mk only colonies anti-correlate with CD41 protein expression of originally sorted LT-HSCs
(i.e., SL-MkPs). The Mk colony size was determined on day 14 of culture.
(C) Venn diagram illustrating that Mk proteins upregulated in HSCs upon inflammation are typically localized to alpha-granules in platelets.
(D) Electronmicroscopy visualization of HSCs, CD41low, and CD41high HSCs fromPBS and pI:C treatedmice 16 hr after treatment. TheMVBs aremarked in red.
(E) Quantification of MVBs.
(F) Quantification of cell size based on stereology analysis of electron micrographs.
(G) Bone sections and quantification of polyploidMks. The bone sections were stained with CD150 (red), Nectin (green), and DAPI (blue) 16 hr after treatment. The
polyploid Mks were quantified using Hoechst staining and FACS.
(H)Quantification of polyploidy in stemand progenitor cell populations 16 hr after PBS and pI:C treatment. The representative histogram ofMkPs is shown at the top.
In (A), (E), (G), and (H), data are presented as mean ± SEM with nR 3. The significance was determined using a Mann-Whitney-Wilcoxon test (A and E), or an
unpaired, two-tailed student’s t test (G and H) (*p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001, and non-significant: NS). See also Figure S3.
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Figure 4. Megakaryocytic Protein Upregulation in HSCs Is Mediated by a Post-Transcriptional Mechanism
(A) Comparison of log2 fold changes in protein level and transcript level of HSCs, isolated from PBS and pI:C treated mice, 16 hr after treatment. The protein and
transcript levels derived from proteomics and qPCR, respectively. The genes marked with asterisks were not detected on transcript level.
(B) Scatterplot view from data presented in (A).
(C) Time-course qPCR analysis of Mk (blue) and IFN response gene (red) transcripts at indicated time points after treatment with pI:C in HSCs.
(D) Translational activity of HSCs upon inflammation. The OP-Puro incorporation was measured 16 hr after PBS/pI:C and 1.5 hr after OP-Puro administration
(see Supplemental Information).
(E) Ribosomal profiling ofMk transcripts upon inflammation. ThemRNA levels of housekeeping (Sdha) andMk genes (others) weremeasured in both fractions and
normalized to Actb.
In (C)–(E), data are presented as mean ± SEM with nR 3. The significance was determined using an unpaired, two-tailed student’s t test (*p% 0.05, **p% 0.01,
***p% 0.001, ****p% 0.0001, and non-significant: NS). See also Figure S4.smaller overall size of Mk colonies (Figure S2C). Interestingly,
CD41 expression of the colony-initiating SL-MkPs and MkPs
was anti-correlative with both the expansion potency of the
cell and with the time required to generate the first mature Mk
(Figure 3B). Hence, the most primitive SL-MkPs with low Mk
protein expression generate the largest Mk colonies at late
time points, while cells with high Mk protein expression generate
smaller Mk colonies at early time points. In contrast to SL-MkPs,
inflammation had no impact onMkmaturation time or the overall
amount of mature Mks generated from HSCs with mixed colony
potential (Figure S2C).
Alpha granules or their precursors in the form of multivesicular
bodies (MVBs) are typical features of megakaryocytic maturation
(Heijnenet al., 1998).ComparisonofMkproteins thatweresynthe-
sized upon inflammation in HSCs with the platelet alpha-granule
proteome (Browne et al., 2001) revealed that the majority of these
proteins are typically localized to alpha granules (Figure 3C). In
accordance with this, electron microscopy and immunofluores-
cence microscopy of purified HSCs revealed the generation of
MVB-like structures 16 hr after induction of inflammation, which
was correlated with the upregulation of Mk proteins and was a
particularly frequent event in CD41high SL-MkPs (Figures 3D, 3E,
and S3A–S3C). Electron microscopy and FACS analysis revealed
an IFNAR-STAT1 and mTOR dependent cell size increase of
HSCs, which was particularly attributed to SL-MkPs that upregu-
late Mk proteins (Figures 3F, S3D, and S3E).
Polyploidy is a characteristic feature of terminally maturated
Mks (Machlus and Italiano, 2013). A strong increase in theCenumber of polyploidMkswas observed 16 hr after pI:C treatment
(Figure 3G). Quantifying ploidy levels in stem and progenitor cell
populations revealed that, in particular, MkPs were driven into
endomitosis in an IFNAR-STAT1 dependent manner, whereas
phenotypic LT-HSCs did not enter endomitosis (Figures 3H
and S3F). Together, these data suggest that inflammation drives
a rapid and efficient cellular maturation program of both SL-
MkPs and MkPs. SL-MkPs are maintained in a highly potent
and primitive state during homeostasis, but are efficiently
pushed towardmaturation upon inflammation, adapting an inter-
mediate state between homeostatic SL-MkPs and classical
MkPs. In contrast to classical MkPs, which are driven into
endomitosis forming mature Mks, SL-MkPs are pushed toward
maturation without directly undergoing endomitosis, thereby
maintaining their high proliferative expansion capacity.
Inflammation-Driven Upregulation of Megakaryocytic
Proteins in Phenotypic HSCs Is Mediated by a
Post-Transcriptional Mechanism
To determine whether the increase in Mk proteins is transcrip-
tionally controlled, we compared transcript and protein levels
of HSCs 16 hr after induction of inflammation. As expected,
IFN response genes were regulated at the transcriptional
level with a high induction of transcripts, resulting in enhanced
protein production (Figures 4A, 4B, and S4A) (Platanias,
2005). In contrast, Mk genes remained unchanged or were
even downregulated at the transcriptional level, while the corre-
sponding proteins were significantly increased (Figures 4A, 4B,ll Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc. 427
and S4A), suggesting a pI:C-induced non-transcriptional regu-
lation of Mk protein expression. In accordance with this, tran-
scription factors regulating Mk gene transcription remained un-
affected at the transcript and protein level (Figures 4A, 4B, and
S4A). Time course experiments demonstrated a rapid transcrip-
tional induction of IFN response genes, whereas Mk transcripts
showed no or only minor increase, excluding the possibility of
elevated protein levels caused by an early transcriptional induc-
tion of Mk genes (Figure 4C). Several scenarios are conceivable
to explain such a non-transcriptional increase in Mk proteins.
Whole platelets, or platelet-derived microparticles (PMPs)
containing Mk proteins, may adhere to or be taken up by
HSCs. However, antibody-mediated depletion of platelets did
not affect pI:C-mediated Mk protein increase, suggesting that
Mk proteins were not of platelet origin (Figure S4B). Since
most Mk transcripts were detected at high levels in HSCs, we
reasoned that inflammation-mediated Mk protein production
might be a result of increased translation of transcripts that
are already present during homeostasis. To measure global
levels of translation in phenotypic HSCs, we made use of an
O-propargyl-puromycin (OP-Puro)-based method, which facili-
tates the measurement of translational rates on single-cell
level in vivo (Liu et al., 2012; Signer et al., 2014). In accordance
with a recent study, homeostatic HSCs showed very low
levels of translational activity (Signer et al., 2014), but had signif-
icantly increased translational rates upon pI:C treatment (Fig-
ure 4D). Importantly, increased translational activity correlated
with enhanced Mk protein expression (Figure S4C). In accor-
dance with an enhanced translational activity, phenotypic
HSCs demonstrated reduced levels of the translation inhibitors
Pdcd4 and Eef2k upon pI:C treatment, which negatively regu-
late the translation initiation and elongation factors Eif4a and
Eef2 (Dorrello et al., 2006; Kruiswijk et al., 2012) (Figure S4D).
Occupancy of transcripts at ribosomes is a strong indication
of translational activity (Ingolia et al., 2012). Accordingly, Mk
transcript occupancy at ribosomes significantly increased
upon induction of inflammation, suggesting enhanced transla-
tion of these transcripts (Figures 4E and S4E). Together, these
experiments suggest that even though most Mk transcripts
are expressed in phenotypic HSCs, translation of these tran-
scripts is repressed during homeostasis. In contrast, pI:C treat-
ment instructs efficient translation, resulting in an enhanced Mk
protein production.
SL-MkP Commitment Is Associated with a Coordinated
Mk Transcription Program Providing Transcriptional
Templates for Inflammation-Driven Protein Synthesis
Even though high expression of Mk transcripts in phenotypic
HSCs has been well documented (Gekas and Graf, 2013; Ma˚n-
sson et al., 2007; Sanjuan-Pla et al., 2013), the mechanistic
role of transcriptional priming is poorly understood. Our data
suggest that Mk transcripts are expressed during homeostasis
and serve as a template for an efficient inflammation-induced
emergency Mk protein synthesis program in SL-MkPs. Accord-
ing to this model, high expression of Mk transcripts in SL-MkPs
would be required for mounting an efficient inflammation-medi-
ated post-transcriptional increase in Mk proteins, whereas low
Mk transcriptional priming in HSCs would explain their attenu-
ated response.428 Cell Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc.To characterize Mk lineage priming in HSCs, SL-MkPs, and
classical MkPs, we measured Mk and control transcripts of
individual MkPs and CD41 sub-populations of LT-HSCs from
PBS and pI:C treated mice by single-cell quantitative (q)PCR.
In accordance with a previous report, all investigated Mk
transcripts were expressed in a bimodal fashion in HSCs, with
Cycle-threshold differences (DCt) of 15-20 between high-ex-
pressing cells and low-expressing cells, suggesting thatMk tran-
scripts are expressed in an ‘‘ON’’ or ‘‘OFF’’ state (Figure 5A) (Guo
et al., 2013). Heatmap representation and principal component
analysis (PCA) of this data revealed that all MkPs expressed
Mk transcripts to high homogenous levels, whereas most LT-
HSCs with homeostatic CD41 levels (CD41low/med HSCs)
expressed a unique combination of Mk transcripts in the ON
or OFF state. This was reflected in a funnel-shaped cloud, with
each cell occupying a unique location in our PCA analysis,
suggesting a stochastic Mk transcript expression (Figures 5B
and 5C). Interestingly, some homeostatic LT-HSCs clustered
together at the tip of the funnel, representing cells with a coordi-
nated Mk transcription profile with all Mk transcripts in the ON
state. Of note, almost all CD41high HSCs from pI:C treated
mice (i.e., SL-MkPs) expressed all Mk transcripts in the ON state
and clustered together with these cells at the tip of the funnel
(Figures 5B–5D), demonstrating that homeostatic SL-MkPs
exhibit a coordinated Mk transcription profile and efficiently
upregulateMk protein synthesis upon inflammation. The hypoth-
esis that commitment of HSCs to SL-MkPs is associated with a
switch from a stochastic toward a coordinated Mk transcription
program was further supported by a significant drop in the Fano
factor, an indicator for a system’s stochasticity and transcrip-
tional noise (Figure S5A) (Munsky et al., 2012; Ozbudak et al.,
2002).
Profiling of transcription factors (TFs) in single HSCs revealed
that expression of many known Mk TFs correlated with Mk-
commitment (e.g., highest expression in classical MkPs and
SL-MkPs) and expression of Mk lineage transcripts (Figures
S5B–S5D). This suggests that Mk transcriptional priming and
Mk lineage commitment of SL-MkPs are established by tran-
scriptional regulators during homeostasis, while inflammation
drives a post-transcriptional Mk protein synthesis from these
pre-existing transcripts.
To investigate how closely related multipotent HSCs and SL-
MkPs are, we performed global gene expression analysis of sin-
gle HSCs and LincKit+CD150 progenitors using a customized
single-cell RNA-sequencing (seq) approach. In accordance with
our single-cell qPCR data, Mk transcripts were significantly
enriched among the most variably expressed genes and Mk
lineage priming differed dramatically between individual HSCs,
whereas progenitors consistently showed little or no Mk lineage
transcript expression (Figures S5E, 5E, and 5F). To determine
whether the transcriptome of HSCs with high Mk lineage priming
differs from HSCs with low Mk lineage priming, we performed
PCA of HSCs and color-coded each cell with a calculated Mk
Gene Set Enrichment Analysis (GSEA)-score reflecting the de-
gree of Mk lineage priming (Figure 5G). Importantly, genome-
wide expression profiles did not correlate with the degree of
Mk-lineage priming, suggesting that Mk-primed HSCs (e.g.,
SL-MkPs) and HSCs with low Mk lineage priming are highly
related cell types. Together, these data suggest that multipotent
A B
C D
E G
F
Figure 5. HSCs Switch from a Stochastic to a Coordinated Mk Transcript Expression Program upon Commitment fromMultipotency toward
the Mk Lineage
(A–D) Single-cell qPCR of LT-HSC CD41 sub-populations. (A) Bean plot representation of Mk transcripts of MkPs and LT-HSCs with homeostatic CD41
expression (CD41low and CD41med) of PBS or pI:C treated mice or with elevated CD41 levels (CD41high and SL-MkPs) of pI:C treated mice. (B) Heatmap
indicating transcript expression of housekeeping genes (Sdha, Oaz1, and Actb), IFN response genes (Ddx58 and Isg15), and Mk genes (others). (C) PCA of CD41
sub-populations of LT-HSCs based on their Mk transcript expression values. The labels are as indicated in (D). (D) Transcript expression of Vwf versus Pf4 (left)
and Treml1 versus Gp1bb (right). The expression values are presented as Ct-values.
(E–G) Single-cell RNA-seq of LincKit+CD150+CD48 HSCs and LincKit+C150- progenitors. (E) Heatmap of HSCs and progenitors showing expression of Mk
and platelet cluster genes in individual cells that were detected with at least 50 reads per cell on average and were significantly differentially expressed. (F) GSEA
of Mk cluster genes in single HSCs and progenitors. The exemplary GSEA profiles are shown. (G) PCA of HSCs based on their overall transcriptome. The
individual cells are color-coded according to their Mk GSEA enrichment score (ES). See also Figure S5.HSCs and SL-MkPs exhibit a related overall transcriptome, how-
ever, commitment from multipotent HSCs to SL-MkPs is asso-
ciated with a switch from a stochastic to a coordinated Mk
transcription program. High transcriptional Mk priming provides
SL-MkPs with the appropriate transcripts to mount an efficient
post-transcriptional Mk protein synthesis program upon inflam-
matory signaling.CeSL-MkPs Represent an Mk-Committed Sub-Population
of VWF+ HSCs
VWF+ HSCs represent a multipotent, but Mk-biased, sub-popu-
lation of HSCs that has been defined by high transcriptional
expression of the Vwf gene (Sanjuan-Pla et al., 2013). To directly
compare SL-MkPs with VWF+ HSCs, we separated LT-HSCs
depending on their Vwf transcriptional activity (Figure S5F).ll Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc. 429
VWF+ HSCs showed an enriched Mk transcriptional priming
if compared to VWF HSCs (Figure S5F) (Sanjuan-Pla et al.,
2013). However, only a small sub-fraction of VWF+ HSCs
showed expression of all Mk transcripts. In contrast, SL-MkPs
uniformly showed high expression of all Mk genes including
Vwf, correlating with their commitment to the Mk-lineage.
Thus, SL-MkPs represent an Mk-committed sub-population of
VWF+ HSCs. These data are consistent with a model where
VWF+ HSCs preferentially give rise to SL-MkPs, thereby estab-
lishing the Mk-bias of multipotent VWF+ HSCs.
The Most Potent and Primitive SL-MkPs Reside in a
Dormant State and Are Efficiently Activated upon
Inflammation
The most potent HSCs are maintained in a long-term quiescent
(dormant) state where they serve as a reserve pool for conditions
of acute stress (Wilson et al., 2008). Long-term quiescent, label-
retaining cells (LRCs) can be identified in the HSC compartment
using doxycyclin (dox) treatment of SCL-tTA:H2B-GFP mice
(Wilson et al., 2008). Whether dormant lineage-restricted pro-
genitors exist in the phenotypic HSC compartment is unknown.
Interestingly, an inflammation-mediated increase in Mk protein
expression, cell size, and granularity could be observed both in
non-LRC LT-HSCs and in dormant LRC LT-HSCs, suggesting
that SL-MkPs also exist in a dormant state (Figures 6A–6C,
S6A, and S6B). Accordingly, single-cell ex vivo lineage tracking
showed that SL-MkPs exclusively generating mature Mks
could be found both in the non-LRC fraction and in the dormant
LRC fraction of the LT-HSC compartment. Interestingly, dormant
SL-MkPs formed larger Mk-colonies and required a longer time
to generate the first mature Mks when compared to their non-
LRC counterparts (Figure 6D). This suggests that the most prim-
itive and most potent SL-MkPs reside in a dormant state and,
hence, do not contribute to steady-state megakaryopoiesis.
To investigate whether quiescent SL-MkPs are activated upon
inflammation, we measured cell cycle activity in HSC CD41 sub-
populations. Ki67-Hoechst and BrdU incorporation assays re-
vealed a rapid and efficient cell cycle entry of SL-MkPs that
increased Mk protein levels 16 hr post pI:C treatment, whereas
the remaining HSC pool was activated at later time points (Fig-
ures 6E–6G and S6E). Accordingly, inflammation triggered by
LPS or TNFa injection resulted in a similar cell cycle induction
of these SL-MkPs that increased Mk protein levels (Figure S6C),
demonstrating that distinct inflammatory signals efficiently acti-
vate quiescent SL-MkPs.
FoxO3a is a key TF that instructs transcription of the cell cycle
inhibitors p27, p57, p107, and p130, thereby maintaining HSCs
in a quiescent state (Miyamoto et al., 2007; Tothova andGilliland,
2007). Cell cycle entry of HSCs is frequently associated with
FoxO3a phosphorylation and subsequent exclusion from the nu-
cleus (Tothova and Gilliland, 2007). In phenotypic HSCs from
control mice and HSCs from pI:C treated mice with homeostatic
CD41 expression, FoxO3a was localized mainly to the nucleus.
In contrast, in CD41high HSCs (i.e., SL-MkPs) from pI:C treated
mice, FoxO3a was frequently redirected to the cytoplasm, sug-
gesting that FoxO3a inactivation is associated with inflamma-
tion-induced cell cycle entry of SL-MkPs (Figures 6H and S6D).
In accordance, a significant decrease in expression of FoxO3a
targets p27, p57, p107, and p130 was specifically observed in430 Cell Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc.SL-MkPs that increased Mk proteins, whereas p19, which is
not a FoxO3a target, remained unchanged (Figure 6I). Together,
these data suggest that acute inflammation triggers FoxO3a
inactivation and efficient cell cycle activation of quiescent
SL-MkPs.
Repeated Cycles of Type-I IFN Mediated Inflammation
Trigger the Exhaustion of SL-MkPs and Other
Megakaryocytic Progenitors
We have shown that a single induction of inflammation drives
maturation of SL-MkPs andMkPs. Accordingly, repeated cycles
of inflammation over a long time period would be anticipated to
result in an exhaustion of these cell types. To investigate this
hypothesis, mice were treated with pI:C every 3 days for a time
period of 30 days (ten doses) (Figure 7A). While a single pI:C
dose resulted in an augmented Mk protein production in HSCs
and MkPs, as well as in an increase in mature polyploid Mks
as described above, inflammation-mediated Mk protein produc-
tion and the number of MkPs and mature polyploid Mks was
significantly reduced upon repeated doses of pI:C (Figures 7B–
7D). Regeneration from platelet consumption after single pI:C
treatment was accomplished within 7 days, whereas after ten
doses, the hematopoietic system required longer to rebuild the
platelet pool, reflecting the reduction in MkPs and SL-MkPs (Fig-
ure 7E). These data indicate that repeated cycles of pI:C-medi-
ated inflammation can result in a transient exhaustion of MkPs
and SL-MkPs due to a constant drive toward maturation, which
prevents an efficient platelet recovery after inflammation-medi-
ated platelet loss.
DISCUSSION
During infection, platelets actively counteract infectious agents
by releasing immunomodulatory agents and interacting with
neutrophils to trap pathogens (Jenne et al., 2013; Yeaman,
2014), thereby, being rapidly consumed. Since low platelet levels
during inflammation are associated with loss of vascular integrity
and septic shock (Goerge et al., 2008; Xiang et al., 2013), a rapid
recovery of platelet levels is of fundamental importance. We
show that inflammatory signaling instructs a rapidMkmaturation
program at distinct levels of megakaryopoiesis to regenerate the
lost platelet pool. While MkPs are efficiently driven into endomi-
tosis, leading to a strong increase in mature Mks, a small pool of
potent Mk-committed progenitors (SL-MkPs) within the pheno-
typic HSC compartment replaces the lost MkPs. Even though
SL-MkPs and classical MkPs appear to be closely related in their
lineage potential and their coordinated Mk transcription pro-
file, SL-MkPs share many features with HSCs which set them
apart from MkPs. Similar to HSCs, and in contrast to MkPs,
SL-MkPs are small in cell size, suppress Mk protein production,
and are mainly quiescent. Due to their quiescent, partly dormant
nature, SL-MkPs contribute little to steady-state megakaryopoi-
esis, but serve as an emergency pool for inflammatory insult.
As a result of their quiescence and the suppression of Mk
protein production, SL-MkPs are maintained in a metabolically
inactive, but primed, state, allowing them to be readily activated.
Inflammatory signaling triggers FoxO3a inactivation, resulting in
cell cycle activation of quiescent SL-MkP. Moreover, inflamma-
tion-mediated maturation of SL-MkPs is associated with mTOR
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Figure 6. The Most Potent and Primitive SL-MkPs Reside in a Dormant State and Are Efficiently Activated upon Inflammation
(A–D) LRC assays. The dormant HSCs were labeled by administering dox to SCL-tTA:H2B-GFP mice for 60 days, followed by PBS or pI:C treatment. Subse-
quently, Mk protein expression was measured in HSCs (B and C) or mice were subjected to single-cell ex vivo lineage tracking (D). (A) Illustration of experimental
approach. (B) Representative FACS plots after 60 days of chase, followed by PBS or pI:C treatment, in LT-HSCs. (C) Quantification of Mk protein expression. (D)
Mk only colonies formed from GFPlow non-LRC-HSCs and GFPhigh LRC-HSCs. The number of mature Mks formed at day 14 of culture (left). The time until first
mature Mk cell appears in the culture (right).
(E) Representative FACS plots of Ki67-Hoechst cell-cycle stainings of HSC CD41 sub-populations.
(F) Quantification of Ki67-Hoechst cell cycle measurements.
(G) Cell cycle analysis of HSC CD41 sub-populations measured by BrdU incorporation.
(H) Representative confocal microscopy images of indicated CD41 LT-HSCs sub-populations, stained for FoxO3a (red) and DAPI (blue).
(I) Transcript levels of cell cycle inhibitors measured by qPCR in CD41 sub-populations of LT-HSCs.
In (C), (D), (F), (G), and (I), data are presented as mean ± SEM with n R 3. The significance was determined using the Mann-Whitney-Wilcoxon test (D) or an
unpaired, two-tailed student’s t test (F, G, and I) (*p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001, and non-significant: NS). See also Figure S6.and STAT1 dependent increase in cell size, enhancedMk protein
production, and appearance of alpha granular precursors. In line
with our findings, both mTOR and STAT1 signaling have been
previously implicated in megakaryopoiesis (Huang et al., 2007;
Raslova et al., 2006).
During homeostasis, post-transcriptional regulation of gene
expression is a rare event in HSCs and changes in protein
and mRNA levels are highly correlated during commitment
(Cabezas-Wallscheid et al., 2014). In contrast to homeostasis,
our findings reveal the presence of significant post-transcrip-
tional regulation in response to acute inflammation. Our dataCesuggest that Mk transcripts are expressed, but that translation
is repressed during homeostasis, resulting in low Mk protein
production, whereas inflammatory signaling drives efficient
translation of these transcripts, revealing an important role for
Mk lineage priming during emergency megakaryopoiesis. This
model is supported by recent findings demonstrating that
HSCs suppress protein synthesis during homeostasis (Signer
et al., 2014). Our single-cell gene expression data provide novel
insights into the basis of Mk lineage priming and suggest that
multipotent HSCs and SL-MkPs exhibit highly related tran-
scriptomes, but switch from a stochastic to a coordinated Mkll Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc. 431
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Figure 7. Chronic Inflammation Triggers Exhaustion of SL-MkPs and Other MkPs
(A–E) Mice were treated every third day for a 30 day period with pI:C. At 16 hr after the final administration, HSCs andMkPs were FACS-analyzed (B–D) or platelet
recovery was investigated (E). For control purposes, mice were treated with PBS in the same schedule or with PBS and single final pI:C dose. (A) Illustration of
experimental approach. (B) Flow cytometric analysis of Mk protein expression in HSCs or MkPs. (C) Representative FACS plot of LincKit+CD150+ bone marrow
cells and CD41 and CD9 expression. (D) Quantification of MkPs and polyploid Mks. (E) Platelet recovery after chronic and acute inflammation.
(F) Model.
In (B), (D), and (E), data are presented as mean ± SEM with nR 3. The significance was determined using an unpaired, two-tailed student’s t test (*p% 0.05,
**p% 0.01, ***p% 0.001, ****p% 0.0001, and non-significant: NS).transcription program upon commitment frommultipotent HSCs
toward the Mk lineage.
Recent reports suggested the existence of Mk-biased, but
multipotent, HSCs (Sanjuan-Pla et al., 2013; Shin et al., 2014).
SL-MkPs represent a sub-population of VWF+ HSCs, which in
contrast to the VWF+ HSCs are homogenously restricted to
the Mk lineage reflected in their coordinated Mk transcription
profile. A preferential commitment of Mk-biased HSCs to SL-
MkPs could explain their intrinsic Mk lineage bias. In accordance
with our data, single-cell transplantations of phenotypic HSCs
revealed the existence of Mk-restricted progenitors with high
self-renewal activity probably directly originating fromHSCs (Ya-
mamoto et al., 2013), likely representing the cells defined by our
study as SL-MkPs.
In this study, wemake use of CD41 expression to discriminate
SL-MkPs during inflammation. During homeostasis, CD41 is ex-
pressed at low levels by HSCs and other myeloid progenitors
(Gekas and Graf, 2013; Yamamoto et al., 2013). Due to an
intrinsic repression of Mk protein synthesis, SL-MkPs express
CD41 to similar levels as HSCs during homeostasis, but effi-
ciently induce CD41 expression upon inflammatory signaling.432 Cell Stem Cell 17, 422–434, October 1, 2015 ª2015 Elsevier Inc.This suggests that high expression of CD41 is a marker for Mk
commitment, while CD41 has broader roles in hematopoiesis
as highlighted by the fact that CD41/mice display multilineage
hematopoietic defects (Gekas and Graf, 2013). A recent study
reported an increased CD41 expression in HSCs upon aging
(Gekas and Graf, 2013). Accordingly, also the expression of
other Mk proteins such as CD62P and Vwf increased in the
phenotypic HSC compartment upon aging, and treatment of
aged mice with pI:C triggered Mk protein synthesis to even
higher levels (data not shown). These data are in line with a
potential expansion or enhanced maturation of SL-MkPs during
aging.
While acute inflammatory signaling drives rapid maturation of
MkPs, resulting in increased platelet production, repeated cycles
of type-I IFN-mediated inflammation can trigger a constant
push of maturation and thus a partial exhaustion of MkPs. These
findings reveal that depending on the context and timing, the
same inflammatory stimuli can be associated with opposing
effects on megakaryopoiesis. This sheds light on the question
of why some inflammatory states and diseases are associated
with thrombocytosis,whereasothers provoke thrombocytopenia
(Cole et al., 1998; Kawamoto, 2003; Martin and Shuman, 1998;
Rajan et al., 2005).
EXPERIMENTAL PROCEDURES
In Vivo Treatments
To induce an inflammation, mice were injected intraperitoneal with a single
dose of 5 mg/kg pI:C (Invitrogen), 0.25 mg/kg LPS (Sigma), or 0.75 mg/kg re-
combinant TNFa (PeproTech). Alternatively, mice were treated every third day
for 30 days with 5mg/kg pI:C. Platelet depletion was performed by intravenous
injection of 2 mg/kg rat monoclonal antibody directed against mouse GPIb
(Emfret Analytics). For transient mTOR blockage, mice were pretreated with
1.5 mg/kg rapamycin 2 hr prior to pI:C treatment.
Transplantation Experiments
For transplantationexperiments,LincKit+CD150+CD48CD34CD41low/med/high
HSC populations were FACS-sorted from ACTB-dtTomato mice. 40 HSCs
together with 23 105 supportive CD45.2+ WT BMwere transplanted intrafemor-
ally into lethally irradiated (23 500 radiation absorbed dose [rad]) CD45.2+ recip-
ientmice.Peripheral bloodwascollectedat indicated timepointsandanalyzed for
tomato+ cells by flow cytometry.
Quantitative Proteomics
Proteomic analysis was performed as described previously (Cabezas-Wall-
scheid et al., 2014), with minor differences.
H2B-GFP Label-Retention Assays
In vivo label-retention assays using SCL-tTA:H2B-GFP mice were performed
as previously described (Wilson et al., 2008). SCL-tTA:H2B-GFP mice were
maintained on water containing 2 mg/ml doxycyline hydrate (Sigma) in 5%
glucose for a 60 day chase period.
Single-Cell qPCR and Single-Cell RNA-Seq
Single cells were directly sorted into PCR-tubes loadedwith lysis buffer using a
BD FACSAria II (BD Bioscience) under the single-cell mode. Single-cell qPCR
was essentially performed as previously described (Guo et al., 2013), with mi-
nor differences. Single-cell RNA-seq was performed according to a modified
version of the QUARTZ-Seq protocol (Sasagawa et al., 2013).
Single-Cell Ex Vivo Lineage Tracking
Single-cell ex vivo lineage tracking was performed according to a modified
version of the approach described by Eilken et al. (2009).
Electron Microscopy
Transmission electron microscopy was performed as described previously
(Platani et al., 2009), with minor differences.
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